247 related articles for article (PubMed ID: 21083656)
1. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.
Bayraktar S; Bayraktar UD; Stefanovic A; Lossos IS
Br J Haematol; 2011 Jan; 152(1):72-80. PubMed ID: 21083656
[TBL] [Abstract][Full Text] [Related]
2. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
3. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma--Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System.
Ohga S; Nakamura K; Shioyama Y; Sasaki T; Yamaguchi T; Yoshitake T; Terashima K; Asai K; Matsumoto K; Honda H
Anticancer Res; 2015 Jun; 35(6):3591-7. PubMed ID: 26026132
[TBL] [Abstract][Full Text] [Related]
5. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study.
Desai A; Joag MG; Lekakis L; Chapman JR; Vega F; Tibshirani R; Tse D; Markoe A; Lossos IS
Blood; 2017 Jan; 129(3):324-332. PubMed ID: 27789481
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
7. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
8. Examining the utility of lower dose radiotherapy for localised primary ocular adnexal MALT lymphoma.
Leeson S; Jayamohan J; Vu H; Sundaresan P
J Med Radiat Sci; 2021 Sep; 68(3):269-273. PubMed ID: 33675287
[TBL] [Abstract][Full Text] [Related]
9. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.
Rosado MF; Byrne GE; Ding F; Fields KA; Ruiz P; Dubovy SR; Walker GR; Markoe A; Lossos IS
Blood; 2006 Jan; 107(2):467-72. PubMed ID: 16166588
[TBL] [Abstract][Full Text] [Related]
10. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions.
Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY
Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620
[TBL] [Abstract][Full Text] [Related]
11. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
13. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
[TBL] [Abstract][Full Text] [Related]
16. Primary radiotherapy for localized orbital MALT lymphoma.
Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal MALTomas: case series of patients treated with primary radiation.
Russell W; Herskovic A; Gessert D; Cohen JA; Rubenstein JB; Gregory SA
Clin Adv Hematol Oncol; 2013 Apr; 11(4):209-14. PubMed ID: 23604236
[TBL] [Abstract][Full Text] [Related]
18. [The preliminary observation of intralesional rituximab administration in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Yang JP; Pang X; Zhang K; Wang LL; Zhu Y
Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):839-845. PubMed ID: 33152842
[No Abstract] [Full Text] [Related]
19. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma.
Jonak C; Troch M; Kiesewetter B; Lukas J; Müllauer L; Jäger U; Chott A; Raderer M
Haematologica; 2012 May; 97(5):766-70. PubMed ID: 22180423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
